Suppr超能文献

急性心力衰竭患者蛋白尿的预后价值

Prognostic values of proteinuria in patients with acute heart failure.

作者信息

Akama Yuka, Matsue Yuya, Maeda Daichi, Dotare Taishi, Sunayama Tsutomu, Iso Takashi, Fujimoto Yudai, Nakade Taisuke, Yatsu Shoichiro, Ishiwata Sayaki, Nakamura Yutaka, Suda Shoko, Kato Takao, Hiki Masaru, Kasai Takatoshi, Minamino Tohru

机构信息

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

J Cardiol. 2025 Jul;86(1):83-87. doi: 10.1016/j.jjcc.2025.01.010. Epub 2025 Jan 28.

Abstract

BACKGROUND

Renal dysfunction is significantly associated with poor prognosis in patients with heart failure. However, the prognostic significance of proteinuria as a potential marker of an impaired glomerular filtration barrier in acute heart failure (AHF) remains unclear. We aimed to investigate the prognostic value of urinary protein/creatinine ratio (PCR) in patients with AHF.

METHODS

Urinary protein levels measured at admission were adjusted for urinary creatinine concentrations in 346 patients (75 ± 13 years; 61 % men) with AHF. Patients were categorized based on urinary PCR, adhering to the Japanese chronic kidney disease (CKD) guideline cut-offs for CKD staging: A1 (<0.15 g/gCr), A2 (0.15-0.49 g/gCr), and A3 (≥0.5 g/gCr). The primary endpoint was all-cause mortality.

RESULTS

Overall, there were 85, 126, and 135 patients in the A1, A2, and A3 groups, respectively. Groups A2 and A3 were associated with lower hemoglobin levels, higher blood urea nitrogen and N-terminal pro-B-type natriuretic peptide levels, and poor renal function. Moreover, groups A2 and A3 had high cystatin C, alpha 1 microglobulin, and urinary liver-type fatty acid-binding protein (L-FABP) levels. Urinary PCR correlated more with tubular markers, alpha 1-microglobulin, and L-FABP than with the glomerular marker cystatin C. Over a median follow-up period of 434 (interquartile range: 89-753) days, 72 deaths occurred. Elevated urinary PCR was associated with higher mortality rates (log-rank test, p < 0.001), even after adjusting for other variables [A2 vs. A1: hazard ratio (HR) 2.59, 95 % confidence interval (CI) 0.71-9,55, p = 0.15; A3 vs. A1: HR 4.40, 95 % CI 1.17-16.6, p = 0.029].

CONCLUSIONS

Elevated urinary PCR is more prevalent in patients with AHF and is associated with a higher risk of all-cause mortality, independent of covariates, including glomerular function. Thus, urinary PCR at admission should provide prognostic information independent of glomerular function.

摘要

背景

肾功能不全与心力衰竭患者的不良预后显著相关。然而,蛋白尿作为急性心力衰竭(AHF)中肾小球滤过屏障受损的潜在标志物的预后意义仍不明确。我们旨在研究尿蛋白/肌酐比值(PCR)在AHF患者中的预后价值。

方法

对346例AHF患者(75±13岁;61%为男性)入院时测得的尿蛋白水平进行尿肌酐浓度校正。根据尿PCR将患者分类,遵循日本慢性肾脏病(CKD)指南中CKD分期的截断值:A1(<0.15 g/gCr)、A2(0.15 - 0.49 g/gCr)和A3(≥0.5 g/gCr)。主要终点是全因死亡率。

结果

总体而言,A1、A2和A3组分别有85例、126例和135例患者。A2组和A3组与较低的血红蛋白水平、较高的血尿素氮和N末端B型利钠肽原水平以及较差的肾功能相关。此外,A2组和A3组的胱抑素C、α1微球蛋白和尿肝型脂肪酸结合蛋白(L-FABP)水平较高。尿PCR与肾小管标志物α1微球蛋白和L-FABP的相关性高于与肾小球标志物胱抑素C的相关性。在中位随访期434天(四分位间距:89 - 753天)内,发生了72例死亡。即使在调整其他变量后,尿PCR升高也与较高的死亡率相关(对数秩检验,p<0.001)[A2组与A1组:风险比(HR)2.59,95%置信区间(CI)0.71 - 9.55,p = 0.15;A3组与A1组:HR 4.40,95% CI 1.17 - 16.6,p = 0.029]。

结论

尿PCR升高在AHF患者中更为普遍,并且与全因死亡风险较高相关,独立于包括肾小球功能在内的协变量。因此,入院时的尿PCR应能提供独立于肾小球功能的预后信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验